Serum markers like alpha fetoprotein (AFP), AFP-L3, and DCP are used alongside imaging modalities for HCC screening, with AFP showing limited sensitivity and possible false elevations in non-HCC conditions. Here, AFP is linked to hepatocellular carcinoma.